News tagged with 'Wyeth'

The top five product-defect verdicts in 2009 rose to $620 million, an increase of 52 percent in total value. Jurors may be in the mood to give it back to corporate America.

Pfizer has combined operations with Wyeth, following the closure of a $68 billion acquisition last week. The deal included its subsidiary Fort Dodge Animal Health, which is now part of Pfizer Animal Health.

Diana Levine is in the news again. The woman whose case against Wyeth delivered the death knell to federal preemption in drug product liability cases, today got part of her wish. The drug that took her right arm will now carry a more explicit warning against administering it via IV push.

A risk of ovarian cancer is increased with hormone therapy, this published study finds.  The results echo the Women's Health Initiative study from 2002 that had to be haulted because researchers found an increase in many cancers among women taking hormone therapy.

President Barack Obama Wednesday called for sweeping changes to the Bush administration directive of federal pre-emption that shields companies from lawsuits over their dangerous and defective products.

The Justice Department and several states are accusing drug giant, Wyeth Pharmaceuticals, of cheating Medicaid programs out of hundreds of millions of dollars in rebates by overcharging for its drug, Protonix, used to treat stomach acid.

The state appeals court in Houston has ruled Wyeth must face a personal injury lawsuit filed by a woman who claims Prempro, a hormone-replacement drug, caused her breast cancer.

The Boston U.S. Attorney’s office has subpoenaed financial records belonging to Dr. Scott S. Reuben, an anesthesiologist at Baystate Medical Center in Mass. after it was revealed that he faked data in at least 21 anesthesiology studies favoring the drug companies he received money from. 

Michiganders did not rejoice over the Diana Levine decision by the U.S. Supreme Court last week. The court rejected the federal preemption argument of drugmaker, Wyeth and returned to citizens the right to sue in state court.  That is, unless you live in Michigan, which offers drugmakers immunity from lawsuits. 

One day after the Supreme Court decision, the cameras have left and Diana Levine realizes that even with a decision in her favor and a $6.7 million award for damages, she's still missing most of her right arm. 

Diana Levine herself speaks about the specifics of her case in a video filmed by the Alliance for Justice on the Injuryboard Web site. Alliance for Justice and Wyeth all weigh in today too following the U.S. Supreme Court Decision on Wyeth v. Levine. 

In a victory for consumer rights, the U.S. Supreme Court today ruled that consumers do have the right to sue a pharmaceutical company when it does not make a drug warning label clear enough to prevent injury.  The decision is a defeat for drugmaker, Wyeth and a victory for musician Diana Levine, who had won $7 million in a lower court ruling that Wyeth was challenging.

Pfizer will acquire Wyeth in a cash and stock deal of $68 billion that makes the world's largest drug company even larger.

Wyeth pharmaceutical company has been paying ghostwriters to produce favorable medical journal articles for its drugs. Particularly the female hormone replacement therapy (HRT) drug Prempro, according to Congressional letters seeking more information about the company’s involvement in medical ghostwriting.

Access Denied?: The Fight for Corporate Accountability - a new documentary about the real human faces of federal pre-emption, and how it takes a toll on those already sick and injured. Alliance for Justice is premiering the film to the nation, Tuesday, November 18th and providing viewers with an opportunity to have an on-line chat with the woman's who is the face of federal pre-emption, Diana Levine.